Outrunning pancreatic cancer: the potential impact of exercise on treatment responses

We spoke to Emma Kurz, a PhD earning her MD Degree at NYU Grossman School of Medicine (NY, USA), about her research investigating the link between aerobic exercise and anti-tumor immune activity in models of pancreatic cancer. According to Johns Hopkins Medicine, the 5-year survival rate of pancreatic cancer is 5-10%, partly because it is difficult to detect and is often only caught after it has metastasized, leaving patients with few treatment options. Cancer can weaken the immune system, so a combination of immunotherapy with another treatment, such as chemotherapy, is proving to be a promising way of fighting stubborn...